Srs-Crescent City, LLC
Treatments and capacity
Affiliated Clinicians
Benjamin Fritz, MD · Nephrology
- Emergency Associates Corporation · 1150 M Indian Canyon Dr, Palm Springs, CA 92262 · (760) 323-6511
- Rodolfo R. Batarse, MD, Medical Corporation · 71511 Hwy 111, Suite H, Rancho Mirage, CA 92270 · (760) 773-2200
- Providence Health and Services MT · 500 W Broadway St, Missoula, MT 59802 · (406) 329-5828
Show 1 more office
- Providence Health and Services MT · 500 W Broadway St, Fl 4, Missoula, MT 59802 · (406) 327-1900
Allen S. Mathew, MD · Nephrology
- 2316 Harrison Ave, Eureka, CA 95501 · (707) 444-2534
- 2765 Timber Ridge Ln, Eureka, CA 95503 · (707) 444-2534
Robert F. Quigley, DO · Nephrology
- Oneill Clark Narvarte and Vicks a Professional Corporation · 780 E Washington Blvd, Crescent City, CA 95531 · (775) 322-4550
- Oneill Clark Narvarte and Vicks a Professional Corporation · 2340 S Carson St, Suite a, Carson City, NV 89701 · (775) 322-4550
- Oneill Clark Narvarte and Vicks a Professional Corporation · 5437 Kietzke Ln, Reno, NV 89511 · (775) 322-4550
What Medicare publishes about this clinic
Source: CMS · Released October 28, 2026
Vascular access
Learn about vascular access (opens in a new tab)California clinics: 35 better than expected, 608 as expected, 9 worse than expected. Number of included patients: 50.
Adult patients who had a catheter (tube) left in a vein for at least 3 consecutive complete months, for their regular hemodialysis treatments. Number of included patients: 50.
Patient Experience
April 18, 2025 – January 9, 2026Bloodstream infections
January 1, 2025 – December 31, 2025Infections are reported using a standardized infection ratio (SIR). The SIR compares the actual number of infections at a dialysis facility to the “predicted” number of infections. Lower numbers are better.
Transplant waitlist
California clinics: 143 better than expected, 578 as expected, 2 worse than expected. Number of included patients: 56.
Being added to the waitlist is a necessary step prior to potential receipt of a deceased donor kidney. The two measures in this section are meant to focus on the waitlisting process to improve access to kidney transplantation for ESRD patients.
Readmission and emergency visits after hospital
California clinics: 14 better than expected, 665 as expected, 24 worse than expected. Number of hospitalizations included in hospital readmission summary: 24.
California clinics: 15 better than expected, 665 as expected, 17 worse than expected. Based on 39 discharges.
Deaths, hospital admissions, emergency visits
California clinics: 8 better than expected, 693 as expected, 10 worse than expected. Number of included patients: 130.
California clinics: 17 better than expected, 690 as expected, 11 worse than expected. Number of included patients: 48.
California clinics: 1 better than expected, 650 as expected, 40 worse than expected. Number of included patients: 45.
Transfusions
January 1, 2025 – December 31, 2025California clinics: 2 better than expected, 583 as expected, 20 worse than expected. Number of included patients: 37.
Hemoglobin
January 1, 2025 – December 31, 2025Number of dialysis patients with Hgb data: 15.
Ownership and operations
Common questions about Srs-Crescent City, LLC
Does Srs-Crescent City, LLC offer peritoneal dialysis or home hemodialysis training?
Yes. This clinic offers peritoneal dialysis, but not home hemodialysis training.
Does it have shifts starting after 5 p.m.?
No.
How many dialysis stations does it have?
Srs-Crescent City, LLC has 9 dialysis stations, the number of hemodialysis chairs at the facility.
Does Medicare publish a quality rating for it?
Yes. Medicare's quality rating for this clinic is 2 stars.
Who owns it?
Ownership type: Profit. Date of Medicare certification or recertification: May 3, 2019.
Data Appendix
| № | Measure | Patients | Clinic | National average | California average | Reading |
|---|---|---|---|---|---|---|
| Hemoglobin | ||||||
| 01 | Patients who had average hemoglobin (Hgb) less than 10.0 g/dL | 15 | 33% | 21% | 18% | |
| 02 | Medicare patients with hemoglobin > 12 g/dL | 15 | 0% | 1% | 1% | |
| Dialysis adequacy | ||||||
| 03 | Adult hemodialysis patients with Kt/V ≥ 1.2 | 46 | 68% | 97% | 96% | |
| 04 | Adult peritoneal dialysis patients with Kt/V ≥ 1.7 | 11 | 54% | 93% | 89% | |
| 05 | Pediatric hemodialysis patients with Kt/V ≥ 1.2 | Not available. Footnote 259. | 88% | 69% | ||
| 06 | Pediatric peritoneal dialysis patients with Kt/V ≥ 1.8 | Not available. Footnote 259. | 79% | 68% | ||
| 07 | Pediatric hemodialysis patients with nPCR | Not available. Footnote 259. | 92% | 83% | ||
| Bloodstream infections | ||||||
| 08 | Standardized infection ratio | Not available. Footnote 201. | ||||
| Mineral and bone disorder | ||||||
| 09 | Adult patients with hypercalcemia (calcium > 10.2 mg/dL) | 57 | 5% | 1% | 1% | |
| 10 | Adult patients with serum phosphorus less than 3.5 mg/dL | 53 | 7% | 7% | 7% | |
| 11 | Adult patients with serum phosphorus between 3.5-4.5 mg/dL | 53 | 23% | 21% | 22% | |
| 12 | Adult patients with serum phosphorus between 4.6-5.5 mg/dL | 53 | 26% | 27% | 27% | |
| 13 | Adult patients with serum phosphorus between 5.6-7.0 mg/dL | 53 | 28% | 26% | 26% | |
| 14 | Adult patients with serum phosphorus greater than 7.0 mg/dL | 53 | 17% | 18% | 18% | |
| Survey of patients' experiences | ||||||
| 15 | Star rating of nephrologists' communication and caring | Not available. Footnote 102. | ||||
| 16 | Star rating of quality of dialysis center care and operations | Not available. Footnote 102. | ||||
| 17 | Star rating of providing information to patients | Not available. Footnote 102. | ||||
| 18 | Star rating of the nephrologist | Not available. Footnote 102. | ||||
| 19 | Star rating of the dialysis center staff | Not available. Footnote 102. | ||||
| 20 | Star rating of the dialysis facility | Not available. Footnote 102. | ||||
| 21 | Survey response rate | Not available. Footnote 102. | 24.0% | 24.0% | ||
| Healthcare personnel COVID-19 vaccination | ||||||
| 22 | Percentage of healthcare personnel meeting COVID-19 vaccination requirements | Not available. Footnote 201. | 3% | 4% | ||
| Survival & hospitalization | ||||||
| 23 | Mortality rate (per 100 patient-years) | 130 | 27.8 | 22 | As Expected | |
| 24 | Hospitalization rate (per 100 patient-years) | 48 | 100.4 | 160.7 | As Expected | |
| 25 | Readmission rate | 24 hospitalizations | 21.9% | 27.9% | As Expected | |
| 26 | Transfusion rate (per 100 patient-years) | 37 | 24.1 | 33.6 | As Expected | |
| 27 | Standardized emergency department visit ratio | 45 | 2.2 | 1 | Worse than Expected | |
| 28 | Standardized emergency department visit ratio within 30 days of hospital discharge | 39 hospitalizations | 1.07 | 1.04 | As Expected | |
| 29 | Standardized modality switch ratio | 34 | 0.76 | 1 | As Expected | |
| Kidney transplant waitlist | ||||||
| 30 | First year standardized kidney transplant waitlist ratio | Not available. Footnote 199. | 1 | |||
| 31 | Prevalent patients waitlisted for kidney transplant | 56 | 24.4% | 16.6% | As Expected | |
| Vascular access | ||||||
| 32 | Rate of fistula | 50 | 46.4% | 56.8% | As Expected | |
| 33 | Adult patients with long-term catheter in use | 50 | 17% | 19% | 18% | |